Moreover, the association between K-ras/BRAF mutations and RASSF methylation, particularly whether or not they work synergistically or are mutually exclusive, is controversial in CRCs (Akino et al, 2005; Hesson et al, 2005; Park et al, 2006), and has not been sufficiently investigated in adenomas. This evidence concerns the gene KRAS and adenoma.